paclitaxel resistance, AXL, glutathione-responsive prodrug, activated T cell-derived exosomes, Triple negative breast cancer
Homologous recombination deficiency, DNA methylation, ovarian cancer, epigenetic biomarker, LASSO regression, PARP inhibitor, prognostic signature